Lava Therapeutics grabs $83m Series C

Lava Therapeutics, a Dutch and U.S. biotech company, has raised $83 million in Series C funding.

17 September 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles